Abstract:BACKGROUND:Post-stroke depression (PSD) is common in stroke survivors, with significantly negative effects and serious impairments in terms of personal and social functioning. While both pharmacological and traditional Chinese medicine (TCM) interventions have been administered for PSD, there is still uncertainty about the balance between these and what treatment strategy should be preferred in clinical practice. Therefore, we aim to compare and rank, describing the protocol of a systematic review and network meta-analysis (NMA), the commonly used TCM interventions for PSD. METHODS AND ANALYSIS:We will search CENTRAL (the Cochrane Central Register of Controlled Trials), CINAHL, Embase, PubMed, CBM and PsycINFO, the US National Institutes of Health and the World Health Organisation International Trials Registry Platform search portal from inception to November 2018. There will be no restrictions on language, publication year or publication type. Only randomized clinical trials (RCTs) accessing any TCM treatments against active comparator or other controls for PSD will be included. The primary outcomes will be efficacy (the total number of participants, declining more than 50% on the total score between baseline) and acceptability of treatment (dropout rate due to any cause). A Bayesian NMA will be performed to compare all relative outcome of different TCM interventions. we will conduct the network meta-regression meta-analyses of data on the sex ratio, the types of stroke and the treatment duration of TCM interventions. Potential explanations in extra subgroup analyses according to the results of heterogeneity and inconsistency will be explored, and sensitivity analyses will be conducted to assess the robustness of the findings. TRIALS REGISTRATION NUMBER:PROSPERO CRD42018082400. CONCLUSION:Our study will generate evidence for TCM in the treatment of PSD and help to reduce the uncertainty about the effectiveness of PSD management, which will encourage further suggestions for TCM clinical practice or guideline.

Clinical Research of Chinese and Western Medicine on Post-Stroke Depression

Pathological Mechanism and Drug Therapy for Post Stroke Depression

Research progress of poststroke depression

The Efficacy of Therapies for Post-Stroke Depression in Aging: an Umbrella Review.

Research Progress in the Treatment of Post-stroke Depression with Traditional Chinese Medicine

Thinking on Post-stroke Depression

Systematic Hypothesis for Post-Stroke Depression Caused Inflammation and Neurotransmission and Resultant on Possible Treatments.

Exploration on Regulation and Mechanism of Acupuncture on Post-stroke Depression

A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview

Traditional Chinese medicine for post-stroke depression: A systematic review and network meta-analysis (Protocol).

Efficacy and Safety of Electroacupuncture for Post Stroke Depression: Study Protocol for a Randomized Controlled Trial

Natural Products for the Treatment of Post-stroke Depression

Clinical Practice Guidelines for Post-Stroke Depression in China.

Neural Substrates of Poststroke Depression: Current Opinions and Methodology Trends

New Opinion on the Subtypes of Poststroke Depression in Chinese Stroke Survivors

An Updated Review on Prediction and Preventive Treatment of Post-Stroke Depression

Pharmacological and Psychotherapeutic Interventions for Management of Poststroke Depression

Comparative Effectiveness of Different Forms of Traditional Chinese Medicine for Treatment of Post-Stroke Depression

Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression

Pay Attention to the Early and Late Post-Stroke Depression

Diagnosis and treatment of post-stroke depression in China: a cross-sectional survey of 350 senior clinicians in neurology, geriatrics, and rehabilitation departments